These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34741572)

  • 21. There are no best practices in a pandemic: Organ donation within the COVID-19 epicenter.
    Friedman AL; Delli Carpini KW; Ezzell C; Irving H
    Am J Transplant; 2020 Nov; 20(11):3089-3093. PubMed ID: 32568471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplant after SARS-CoV-2 infection: A systematic review.
    Nacif LS; Fernandes MR; Waisberg DR; Pinheiro RS; Rocha-Santos V; Galvão F; Andraus W; Carneiro-D'Albuquerque L
    Clinics (Sao Paulo); 2022; 77():100042. PubMed ID: 35870265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of the COVID‒19 pandemic on organ donation and transplantation in Hungary in 2020].
    Mihály S; Egyed-Varga A; Trnka-Szántay K; Deme O; Holtzinger E; Nacsa J; Piros L
    Orv Hetil; 2021 Jun; 162(23):890-896. PubMed ID: 34091437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: A report of 10 cases.
    Koval CE; Poggio ED; Lin YC; Kerr H; Eltemamy M; Wee A
    Am J Transplant; 2021 Nov; 21(11):3743-3749. PubMed ID: 34254424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of SARS-CoV-2-Positive donors in pediatric renal transplantation.
    Pizzo H; Soni PR; Nadipuram S; Garrison J; Jordan SC; Puliyanda D
    Pediatr Transplant; 2023 Aug; 27(5):e14451. PubMed ID: 36518031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience.
    Koval CE; Eltemamy M; Poggio ED; Schold JD; Wee AC
    Am J Transplant; 2022 Dec; 22(12):2903-2911. PubMed ID: 36176236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ transplantation using COVID-19-positive deceased donors.
    Bock MJ; Vaughn GR; Chau P; Berumen JA; Nigro JJ; Ingulli EG
    Am J Transplant; 2022 Sep; 22(9):2203-2216. PubMed ID: 35822320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation.
    de la Villa S; Valerio M; Salcedo M; Ortiz-Bautista C; Catalán P; Padilla B; Romero M; Blázquez-Bermejo Z; Pedraz Á; López-Baena JÁ; Hortal J; Bouza E; Alonso R; Muñoz P
    Transpl Infect Dis; 2021 Oct; 23(5):e13664. PubMed ID: 34092025
    [No Abstract]   [Full Text] [Related]  

  • 30. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful lung transplantation using an allograft from a COVID-19-recovered donor: a potential role for subgenomic RNA to guide organ utilization.
    Saharia KK; Ramelli SC; Stein SR; Roder AE; Kreitman A; Banakis S; Chung JY; Burbelo PD; Singh M; Reed RM; Patel V; Rabin J; Krupnick AS; Cohen JI; de Wit E; Ghedin E; Hewitt SM; Vannella KM; Chertow DS; Grazioli A
    Am J Transplant; 2023 Jan; 23(1):101-107. PubMed ID: 36695611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donors.
    Kumar D; Humar A; Keshavjee S; Cypel M
    Am J Transplant; 2021 Jul; 21(7):2623-2624. PubMed ID: 33756058
    [No Abstract]   [Full Text] [Related]  

  • 33. Minipool testing for SARS-CoV-2 RNA in United States blood donors.
    Bakkour S; Saá P; Groves JA; Montalvo L; Di Germanio C; Best SM; Grebe E; Livezey K; Linnen JM; Strauss D; Kessler D; Bonn M; Green V; Williamson P; Kleinman S; Stramer SL; Stone M; Busch MP;
    Transfusion; 2021 Aug; 61(8):2384-2391. PubMed ID: 34046906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Utility of COVID-19 Real Time-Polymerase Chain Reaction Testing of Ocular Tissues of Non-COVID-19 Cornea Donors Deemed Suitable for Corneal Retrieval and Transplantation.
    Chaurasia S; Rudraprasad D; Senagari JR; Reddy SL; Kandhibanda S; Mohamed A; Basu S; Garg P; Joseph J
    Cornea; 2022 Feb; 41(2):238-242. PubMed ID: 34852410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Navigating the COVID-19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States.
    Goff RR; Wilk AR; Toll AE; McBride MA; Klassen DK
    Am J Transplant; 2021 Jun; 21(6):2100-2112. PubMed ID: 33244847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
    La Rosa C; Chiuppesi F; Park Y; Zhou Q; Yang D; Gendzekhadze K; Ly M; Li J; Kaltcheva T; Ortega Francisco S; Gutierrez MA; Ali H; Otoukesh S; Amanam I; Salhotra A; Pullarkat VA; Aldoss I; Rosenzweig M; Aribi AM; Stein AS; Marcucci G; Dadwal SS; Nakamura R; Forman SJ; Al Malki MM; Diamond DJ
    Front Immunol; 2023; 14():1114131. PubMed ID: 36936918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients-Are they safe and provide good outcomes?
    La Hoz RM; Green M
    Pediatr Transplant; 2022 Dec; 26(8):e14406. PubMed ID: 36195970
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.